There are 2949 resources available
1622MO - Clinical benefit with ripretinib as ≥4th line treatment in patients with advanced gastrointestinal stromal tumors (GIST): Update from the phase III INVICTUS study
Presenter: John Zalcberg
Session: Mini Oral - Sarcoma
Resources:
Abstract
Slides
Webcast
1623MO - Ripretinib intra-patient dose escalation (IPDE) following disease progression provides clinically meaningful progression-free survival (PFS) in gastrointestinal stromal tumor (GIST) in phase I study
Presenter: Filip Janku
Session: Mini Oral - Sarcoma
Resources:
Abstract
Slides
Webcast
1624MO - Weekly nab-paclitaxel for progressive or symptomatic desmoid tumors: A multicenter single arm phase II trial from the Spanish Group for Research on Sarcoma (GEIS)
Presenter: Javier Martin Broto
Session: Mini Oral - Sarcoma
Resources:
Abstract
Slides
Webcast
Invited Discussant 83MO, 84MO and 85MO
Presenter: Pierre Laurent-Puig
Session: Mini Oral - Translational research
Resources:
Slides
Webcast
Invited Discussant 86MO, 87MO and LBA10
Presenter: Michael Speicher
Session: Mini Oral - Translational research
Resources:
Slides
Webcast
Invited Discussant 88MO, 1931MO, 1932MO and 1933MO
Presenter: Teresa Davoli
Session: Mini Oral - Translational research
Resources:
Slides
Webcast
Open & welcome
Presenter: Daniel Peeper
Session: Mini Oral - Basic Science
Resources:
Slides
Webcast
Invited Discussant 4MO and 5MO
Presenter: Stefano Trebeschi
Session: Mini Oral - Basic Science
Resources:
Slides
Webcast
Invited Discussant 7MO, 8MO, 1978MO and 1979MO
Presenter: Daniel Peeper
Session: Mini Oral - Basic Science
Resources:
Slides
Webcast
Invited Discussant 6MO, 1980MO and 9MO
Presenter: Ruth Palmer
Session: Mini Oral - Basic Science
Resources:
Slides
Webcast